UiPath Hits 52-Week Low Amid AI Rivalry Fears

NEW YORK, April 28 —

UiPath, Inc. (PATH) has slid to $10.59, a 52-week low that values the robotic process automation pioneer at roughly $5.55 billion. That price tag lands on a company generating $1.61 billion in trailing revenue, 83% gross margins, and nearly half a billion dollars in free cash flow. The reason, per multiple reports: investors think Anthropic and other AI labs will eat UiPath's core business.

The Anthropic Problem

The sell-off comes down to one question: if large language models can read documents, extract data, and trigger workflows, what exactly is UiPath's moat? Retail investors have called the reaction "irrational." The valuation math gives that argument some weight. But the fear is not baseless. UiPath built its business automating tedious, rule-based tasks that sit between enterprise software systems. AI agents from Anthropic, Google, and others promise to do the same thing — with natural language instead of brittle screen-scraping scripts. The open question: is UiPath the platform those agents run on, or the legacy tool they replace?

The Numbers That Don't Match the Price

UiPath has beaten EPS estimates in each of its three most recent reported quarters: $0.11 versus $0.10 estimated, $0.15 versus $0.08 estimated, and $0.16 versus $0.15 estimated, per its March earnings release. An 83.2% gross margin at this scale puts UiPath in elite software territory. Free cash flow of $474 million on $1.61 billion in revenue means the business converts nearly 30 cents of every revenue dollar into cash. At 11.8x forward earnings, the stock is priced as though growth has already flatlined or the competitive threat has already arrived. Neither is true yet.

That gap between operating performance and stock price either corrects or proves prophetic. Right now, the market is betting prophetic.

Leadership Musical Chairs

An 8-K filed March 25 disclosed a departure or appointment of directors or principal officers, accompanied by a Regulation FD disclosure. The filing does not paint a full picture without the underlying press release details. But leadership transitions at a company already under competitive pressure tend to amplify uncertainty, not resolve it. CEO and Chairman Daniel Dines also appeared in three Form 4 filings on March 16, each reflecting "Other" transactions involving 9,615,297 shares. The triple filing of identical share counts looks like a reclassification or trust transfer rather than a sale. Still, the opacity adds another layer of unease for a stock already at multi-year lows.

The AI Hedge

UiPath is not sitting still. On April 27, the company announced a partnership linking Databricks data with AI workflows for real-time action. Separately, reports indicate UiPath is making Google's Gemini core to its document automation platform. Both moves signal the same strategic bet: UiPath's value lies not in the bots themselves but in the orchestration layer connecting AI models to enterprise systems. If companies need a platform to govern, monitor, and route AI agent activity across their tech stacks, UiPath wants to be that platform.

The logic is sound. The execution risk is enormous. Partnering with Databricks and Google means conceding that the AI brains live elsewhere. UiPath becomes the plumbing. Plumbing businesses can be very profitable. They rarely command premium multiples.

What the Insiders Are (Not) Doing

Over the past 90 days, zero insiders made open-market purchases or sales. On April 1, four executives received equity grants: COO/CFO Ashim Gupta (306,748 shares), CTO Raghavendra Malpani (159,125 shares), General Counsel Brad Brubaker (157,208 shares), and CAO Hitesh Ramani (123,466 shares). The concurrent dispositions totaling roughly $2.13 million at $11.10 per share were all tax-withholding transactions — the automatic kind that cover the tax bill on vesting equity. Nobody chose to sell. Nobody chose to buy, either. At a 52-week low, insider buying would be the clearest signal of internal conviction. Its absence is not damning. It is conspicuous.

The Checkpoint

UiPath at 11.8x forward earnings with 83% gross margins and growing free cash flow looks like either a value trap or a steal. The answer hinges almost entirely on timing: is AI competition a near-term threat or a long-term one? Near-term, the Databricks and Gemini partnerships are too fresh to judge. The leadership change from the March 25 filing needs more context. And the Anthropic fear, while directionally valid, has not yet dented UiPath's revenue trajectory or customer retention metrics. The next earnings report is the real test. If growth holds and guidance stays firm, the 52-week low starts looking less like foresight and more like panic.

Run the free UiPath, Inc. deep-dive →

Basis Report does not hold positions in securities discussed. This is not investment advice.